TTBB CAS 124750-51-2 Pite > 96.0% (HPLC) Irbesartan Entèmedyè Faktori

Deskripsyon kout:

Non: 5-(4′-Bromethyl-1,1′-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol

Sinonim: TTBB

CAS: 124750-51-2

Pite:> 96.0% (HPLC)

Aparans: poud blan pou prèske blan

Entèmedyè Irbesartan (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com

Voye imèl ba nou

Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Ruifu Chimik Pwovizyon pou Irbesartan Entèmedyè:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Trityl Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Side Chain Hydrochloride CAS 151257-01-1

Pwopriyete chimik:

Non Chimik	5-(4'-Bromethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol
Sinonim	TTBB;BBTT;5-[4'-Bromethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazol;N-(Triphenylmethyl)-5-(4'-Bromethylbiphenyl-2-yl-)tetrazol;Olmesartan enpurte 12;Losartan Bromo N1-Trityl enpurte
Nimewo CAS	124750-51-2
Nimewo CAT	RF-PI1878
Estati Stock	Nan Stock, Kapasite Pwodiksyon 150MT / Ane
Fòmil molekilè	C33H25BrN4
Pwa molekilè	557,48
Pwen k ap fonn	152.0 ~ 155.0 ℃
Dansite	1.28±0.10 g/cm3
Mak	Ruifu Chimik

Espesifikasyon:

Atik	Espesifikasyon
Aparans	Poud blan pou prèske blan
Pite / Metòd analiz	>96.0% (HPLC)
Pèt sou siye	<0.50%
Enpurte A	<2.00% (HPLC) 5-(4-Methyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol
Enpurte B	<2.00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol
Enfrawouj Spectrum	Konfòm ak estrikti
Tès Creole	Enterprise Standard
Itilizasyon	Entèmedyè nan Irbesartan (CAS: 138402-11-6);Olmesartan Medoxomil enpurte

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite

Avantaj:

FAQ:

Aplikasyon:

5-(4'-Bromometil-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) se yon entèmedyè nan Irbesartan (CAS: 138402-11). -6).Irbesartan yo itilize pou tretman tansyon wo, osi byen ke nefropati dyabetik ak kreyatinin serik ki wo ak proteinuria (> 300 mg / jou) nan pasyan ki gen dyabèt tip 2 ak tansyon wo.Irbesartan se tou itilize kòm yon ajan dezyèm liy nan tretman konges.Irbesartan se yon antagonist reseptè angiotensin II ki itilize sitou pou tretman tansyon wo.Li te devlope pa Sanofi Research (kounye a fè pati Sanofi-Aventis).Sanofi-Aventis ak Bristol-Myers Squibb te mache ansanm sou non komès Aprovel, Karvea, ak Avapro.